Tanja Fehm

Research interests

Publications

• Cancer Risks Associated With BRCA1 and BRCA2 Pathogenic Variants.

  Kölner Universitäts PublikationsServer (Universität zu Köln) · 2021 · https://doi.org/10.17863/cam.78454

• The clinical use of circulating tumor cells (CTCs) enumeration for staging of metastatic breast cancer (MBC): International expert consensus paper

  Critical Reviews in Oncology/Hematology · 2018 · https://doi.org/10.1016/j.critrevonc.2018.12.004

• Presence of Circulating Tumor Cells in High-Risk Early Breast Cancer During Follow-Up and Prognosis

  JNCI Journal of the National Cancer Institute · 2018 · https://doi.org/10.1093/jnci/djy152

• Clinical validity of circulating tumour cells in patients with metastatic breast cancer: a pooled analysis of individual patient data

  The Lancet Oncology · 2014 · 10.1016/s1470-2045(14)70069-5

• Circulating Tumor Cells Predict Survival in Early Average-to-High Risk Breast Cancer Patients

  JNCI Journal of the National Cancer Institute · 2014 · https://doi.org/10.1093/jnci/dju066

• Prognosis of Women With Primary Breast Cancer Diagnosed During Pregnancy: Results From an International Collaborative Study

  Journal of Clinical Oncology · 2013 · https://doi.org/10.1200/jco.2012.45.6335

• HER2 Dimerization Inhibitor Pertuzumab - Mode of Action and Clinical Data in Breast Cancer

  Breast Care · 2013 · https://doi.org/10.1159/000346837

• Borderline tumours of the ovary: A cohort study of the Arbeitsgemeinschaft Gynäkologische Onkologie (AGO) Study Group

  European Journal of Cancer · 2013 · https://doi.org/10.1016/j.ejca.2013.01.035

• 13th St. Gallen International Breast Cancer Conference 2013: Primary Therapy of Early Breast Cancer Evidence, Controversies, Consensus - Opinion of a German Team of Experts (Zurich 2013)

  Breast Care · 2013 · https://doi.org/10.1159/000351692

• Treatment of breast cancer during pregnancy: an observational study

  The Lancet Oncology · 2012 · https://doi.org/10.1016/s1470-2045(12)70261-9

• Neoadjuvant Chemotherapy and Bevacizumab for HER2-Negative Breast Cancer

  New England Journal of Medicine · 2012 · https://doi.org/10.1056/nejmoa1111065

• MicroRNA-520/373 family functions as a tumor suppressor in estrogen receptor negative breast cancer by targeting NF-κB and TGF-β signaling pathways

  Oncogene · 2011 · https://doi.org/10.1038/onc.2011.571

• Comparison of estrogen and progesterone receptor status of circulating tumor cells and the primary tumor in metastatic breast cancer patients

  Gynecologic Oncology · 2011 · https://doi.org/10.1016/j.ygyno.2011.04.039

• Detection and HER2 Expression of Circulating Tumor Cells: Prospective Monitoring in Breast Cancer Patients Treated in the Neoadjuvant GeparQuattro Trial

  Clinical Cancer Research · 2010 · https://doi.org/10.1158/1078-0432.ccr-09-2042

• HER2 status of circulating tumor cells in patients with metastatic breast cancer: a prospective, multicenter trial

  Breast Cancer Research and Treatment · 2010 · https://doi.org/10.1007/s10549-010-1163-x

• Systemic Spread Is an Early Step in Breast Cancer

  Cancer Cell · 2008 · 10.1016/j.ccr.2007.12.003

• A Pooled Analysis of Bone Marrow Micrometastasis in Breast Cancer

  New England Journal of Medicine · 2005 · https://doi.org/10.1056/nejmoa050434

Current projects

No projects listed.